Amphastar Pharmaceuticals(AMPH) - 2025 Q4 - Earnings Call Transcript

Amphastar Pharmaceuticals (NasdaqGS:AMPH) Q4 2025 Earnings call February 26, 2026 05:00 PM ET Company ParticipantsBill Peters - CFODan Dischner - SVP of Corporate CommunicationsPavan Patel - Associate of Biotech & Pharma Equity ResearchSerge Belanger - Managing Director of BioPharma Equity ResearchTony Marrs - EVP of Regulatory Affairs and Clinical OperationsConference Call ParticipantsDavid Amsellem - Managing Director and Senior Research AnalystEkaterina Knyazkova - Equity Research AnalystTianxi Cai - Ana ...